Alzheimer’s jab ‘halves rate of cognitive decline’ in major trial: ‘Very encouraging’

A new drug has halved the rate of cognitive decline in Alzheimer’s patients in a major trial. Patients given low-dose diranersen injections showed 54 per cent less decline on a test of memory and thinking over almost two years, according to the Telegraph.
Alzheimer’s disease, which mostly affects older adults, is thought to be caused by a build-up of proteins, including amyloid and tau, in the brain which affect how the brain cells transmit messages. As time passes, more brain cells are…
A headline and short preview from The Independent. The complete report is published on their website.
Comments 0
Write a comment
Sign in or create an account to comment and react.

.jpeg?width=1200&auto=webp&crop=3%3A2)





No comments yet. Be the first to share your perspective.